Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX‐AHF trial

[1]  Ò. Miró,et al.  Editor’s Choice-The role of the emergency department in the management of acute heart failure: An international perspective on education and research , 2015, European heart journal. Acute cardiovascular care.

[2]  V. Hasselblad,et al.  Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trials , 2016, European journal of heart failure.

[3]  Lihong Chen,et al.  Recent advances in circadian rhythms in cardiovascular system , 2015, Front. Pharmacol..

[4]  A. Shoaib,et al.  Breathlessness at rest is not the dominant presentation of patients admitted with heart failure , 2014, European journal of heart failure.

[5]  P. Pang,et al.  Emergency departments, acute heart failure, and admissions: one size does not fit all. , 2014, JACC. Heart failure.

[6]  P. Ponikowski,et al.  Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF , 2013, European heart journal.

[7]  Piotr Ponikowski,et al.  EURObservational Research Programme: regional differences and 1‐year follow‐up results of the Heart Failure Pilot Survey (ESC‐HF Pilot) , 2013, European journal of heart failure.

[8]  V. Hasselblad,et al.  Predictors of early dyspnoea relief in acute heart failure and the association with 30‐day outcomes: findings from ASCEND‐HF , 2013, European journal of heart failure.

[9]  Nobuaki Kobayashi,et al.  Association between the admission time and the clinical findings in patients with acute heart failure. , 2013, Journal of cardiology.

[10]  P. Ponikowski,et al.  Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. , 2013, Journal of the American College of Cardiology.

[11]  Piotr Ponikowski,et al.  Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial , 2013, The Lancet.

[12]  Francesco Portaluppi,et al.  Circadian rhythms and cardiovascular health. , 2012, Sleep medicine reviews.

[13]  P. Ponikowski,et al.  Design of the RELAXin in acute heart failure study. , 2012, American heart journal.

[14]  N. Hagiwara,et al.  Admission time, variability in clinical characteristics, and in-hospital outcomes in acute heart failure syndromes: findings from the ATTEND registry. , 2011, International journal of cardiology.

[15]  G. Fonarow,et al.  Day of Admission and Clinical Outcomes for Patients Hospitalized for Heart FailureCLINICAL PERSPECTIVE , 2008 .

[16]  C. O'connor,et al.  Day of Admission and Clinical Outcomes for Patients Hospitalized for Heart Failure: Findings From the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) , 2008, Circulation. Heart failure.

[17]  W. Frishman,et al.  Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart Failure , 2007 .

[18]  K. Adams,et al.  Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). , 2005, American heart journal.

[19]  F. Portaluppi,et al.  CIRCADIAN VARIATION IN ONSET OF ACUTE CARDIOGENIC PULMONARY EDEMA IS INDEPENDENT OF PATIENTS' FEATURES AND UNDERLYING PATHOPHYSIOLOGICAL CAUSES , 2000, Chronobiology international.